Ablynx SA
363.5 FTEThe score of Ablynx shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +9 % Equity +1 % Total assets -1 % Headcount (avg FTE) -12 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 16 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ablynx's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jun 2026
- Year ended 31 Dec 2024filed on 03 Jul 2025
- Year ended 31 Dec 2023filed on 08 Jul 2024
- Year ended 31 Dec 2022filed on 17 Aug 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
Ablynx's financial analysis
- Solvency86.1%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ablynx
Ablynx's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0475.295.446
- VAT number
- BE0475295446
- Peppol
- Registered · 0208:0475295446 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 13 Jul 2001
- Registered office
- 9052 Ghent
- Size
- Large · 363.5 FTE
- Latest accounts
- 2025 · filed on 23 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Ablynx (SA) has been based in Ghent since 2001, active in: research and experimental development on biotechnology. For 2025, it reports revenue of €147.9m, a net profit of €3.69m and equity of €359.2m. With 363.5 full-time equivalents, it is a large enterprise by headcount. Its solvency stands at 86.1%, above the median of its sector (60.4%).
Companies similar to Ablynx
Companies in the same business, of comparable size and area, outside its group.
- AgomAb Therapeutics Technical testing and analysis Antwerp · balance sheet €251.3m
- Omega Pharma Innovation & Development Research and experimental development on natural sciences and engineering Ghent · balance sheet €246.6m
- Devgen Research and experimental development on natural sciences and engineering Ghent · balance sheet €130.9m
- Legend Biotech Belgium Research and experimental development on natural sciences and engineering Ghent · balance sheet €142.4m
- MDxHealth Research and experimental development on natural sciences and engineering Herstal · balance sheet €159.3m
- Kaneka Eurogentec Manufacture of pharmaceutical preparations Seraing · balance sheet €115.4m
- Ogeda Research and experimental development on natural sciences and engineering Vilvoorde · balance sheet €53.5m
- UCB Developed Brands Research and experimental development on natural sciences and engineering Anderlecht · balance sheet €1.07bn
Frequently asked questions about Ablynx
What is the revenue of Ablynx?
According to the 2025 annual accounts filed with the NBB, the revenue of Ablynx amounts to 147,918,811 €.
What is the VAT number of Ablynx?
In Belgium, the VAT number is the company number prefixed with BE: BE0475295446 for Ablynx, if the company is VAT-registered. Its company number (CBE) is 0475.295.446.
Where is the registered office of Ablynx?
According to the CBE register, the registered office of Ablynx is in 9052 Ghent.
What is the equity of Ablynx?
At the close of the 2025 financial year, the equity of Ablynx amounts to 359,208,267 €, a solvency of 86.1% of total assets.
How many people work at Ablynx?
363.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Ablynx?
The register lists 3 active mandates at Ablynx. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ablynx
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →